Topics
PSMO 36TH ANNUAL CONVENTION
BRENTUXIMAB Vedotin: Finding a Chance for Cure in HL and other CD30 Lymphomas
PSMO 36TH ANNUAL CONVENTION
The need for standardization: Types of Cancer Treatment Facility Licensing Requirements
PSMO 36TH ANNUAL CONVENTION
Cutting thru Complexities of Early Lung Cancer: From Screening to Personalized Adjuvant Therapy
PSMO 36TH ANNUAL CONVENTION
Bringing Pfizer’s Legacy in Cancer Treatment to Biosimilars
PSMO 36TH ANNUAL CONVENTION
Common Themes of Moral Distress in Oncology